← All trials
NCT05402748
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 22, 2021
- Primary completion
- Dec 22, 2022
- Completion date
- Mar 22, 2023
- First posted
- Jun 2, 2022
- Last posted
- Nov 2, 2022
- Enrollment
- 80
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of TehranLead sponsor
- University of TehranReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.